Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
ClinicalTrials.gov study NCT05456048. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial
ClinicalTrials.gov study NCT06664879. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML
ClinicalTrials.gov study NCT06232694. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04884984. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
ClinicalTrials.gov study NCT06879847. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of G-CSF-Priming in Elderly AML Patients
ClinicalTrials.gov study NCT00199147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00720850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients
ClinicalTrials.gov study NCT03679650. IPD Sharing: NO. Countries: 1. Publications: 0.
VAC Regimen for AML Patients Who Failed to Response to VA Regimen
ClinicalTrials.gov study NCT06220162. IPD Sharing: NO. Countries: 1. Publications: 0.
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
ClinicalTrials.gov study NCT06580106. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
ClinicalTrials.gov study NCT06105658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine and Cytarabine as Continuous Infusion Plus G-CSF Priming for Elderly Patients With Resistant AML
ClinicalTrials.gov study NCT00529880. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IDH Targeted/Non- Targeted vs Non-targeted/IDH-targeted Approaches in the Treatment of Newly Diagnosed IDH Mutated AML Patients Not Candidates for Intensive Induction Therapy (I- DATA Study)
ClinicalTrials.gov study NCT05401097. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML
ClinicalTrials.gov study NCT06268574. IPD Sharing: NO. Countries: 4. Publications: 0.
The Maintenance Treatment of "ITIVA" in AML Patients
ClinicalTrials.gov study NCT06256627. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05580601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Efficacy and Safety of CD47 Monoclonal Antibody Combined With Azacitidine in the Treatment of Recurrent AML After Transplantation
ClinicalTrials.gov study NCT05266274. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML
ClinicalTrials.gov study NCT02255162. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
ClinicalTrials.gov study NCT01489722. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cardioprotection in AML
ClinicalTrials.gov study NCT04977180. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.